Introduction
Coffee is one of the most widely consumed beverages around the world; thus, investigating whether or not coffee consumption is associated with chronic disease risk has important public health implications. The relationship between coffee consumption and risk of coronary heart disease was first studied in the 1960s, given that the prevalence of coffee drinking and CHD were both high in western countries. 1 Short-term metabolic studies found that caffeine ingestion acutely induces cardiac arrhythmias, and increases plasma renin activity, catecholamine concentrations, and blood pressure. 2, 3 In the 1980s, cross-sectional studies found a positive association between coffee consumption and serum total cholesterol concentrations, which might be related to the coffee brewing method (i.e. boiled or unfiltered coffee). 4 A later randomized trial showed that boiled coffee consumption increased the serum cholesterol. 5 From the 1980s to the 2000s, many case-control studies, which are prone to recall and selection bias, showed a positive association between coffee consumption and CHD risk. [6] [7] [8] In contrast, meta-analyses of prospective cohort studies tended to find no association, although results varied substantially across studies. 9, 10 Since 2000, the association between coffee consumption and other cardiovascular disease (CVD) outcomes such as stroke, heart failure, and total CVD mortality has also been more frequently studied. [11] [12] [13] Meta-analyses have been published to summarize the association between coffee and risk of CHD, 14 stroke, 15 and heart failure. 16 These meta-analyses did not support an association between coffee consumption and a higher CVD risk, but the shape of the association remains uncertain. Moreover, a number of additional studies have been published since the publication of these meta-analyses, 11, 13, [17] [18] [19] and one recent meta-analysis paper showed that heavy coffee consumption was not associated with risk of CVD mortality. 20 To be related to the coffee brewing method (i.e. boiled or unfiltered coffee). 4 A lat ter er r r ran a a do do domi mi mize ze zed d rial showed that boiled coffee consumption increased the serum cholesterol. 5 From the 1980s to h he e 20 20 2000 00 00s, s, m m ma a any y ca ca cas se-control studies, which are e pr p p o o one to recall an an nd d se ele le lec ct ction bias, showed a posi si iti t ve assoc cia iati ti t o on n b b be et e we we ween en en c c cof offe fe ee e co co ons nsum mpt ption an n nd CH CH CHD D D ri ri isk sk. . 6-8 -8 8 I In n co cont ntra ra ras st st, , me me meta ta a-a -ana na aly ly lyse se es s of pr pros os ospe pe pect ct c iv ive e e c co coho ho ort t t s stu tu udi dies es ten en nde de ded d d to to to f fin in nd d d no no no ass ss ssoc oc cia a ati t o on on, al al alt th thou ou ough gh gh re re resu su ul lts s va va ari ri r ed ed ed s sub ub ubsta an ant ti tial ally ly y across studies es s. . 9 9 9, 10 10 10 examine the dose response association of coffee consumption with cardiovascular disease risk,
we conducted a systematic review and meta-analysis of coffee consumption and incidence of total CVD outcomes, including incidence of CHD, stroke, and heart failure, and CVD mortality.
Methods
We followed the Meta-Analysis of Observational Studies in Epidemiology 21 protocol throughout the design, implementation, analysis, and reporting of our meta-analysis.
Search strategy and selection criteria
We searched the PubMed and EMBASE databases for prospective studies that had evaluated the association between coffee consumption and risk of CVD between January 1966 and March 2013. The computer-based searches included the key words "coffee", "cardiovascular disease", "coronary heart disease", "stroke", "mortality", "heart failure", "myocardial infarction", "ischemic heart disease", "sudden cardiac arrest", and "acute coronary syndrome". Reference lists of retrieved articles were manually scanned for all relevant additional studies and review articles. We restricted the search to studies on humans that were written in English.
Study Selection
Studies were included in this meta-analysis if they met the following criteria: 1) prospective cohort studies, including case-cohort studies and nested case-control studies with a prospective design; 2) the exposure was coffee consumption, including total coffee, caffeinated coffee, or decaffeinated coffee; 3) the outcome was risk of CVD, including incidence of CHD, stroke, and heart failure, and CVD mortality. Studies were excluded if 1) the study had a retrospective design; 2) the estimates were presented without standard errors or other information that allowed calculation of standard errors; 3) the outcome was atrial fibrillation, atherosclerosis, hypertension, association between coffee consumption and risk of CVD between January 1966 6 and nd n M M Mar ar arch ch ch 2013. The computer-based searches included the key words "coffee", "cardiovascular disease", cardiovascular disease stroke", "mortality "c cor or oron on na ar ary y y he he hea a art di di dis se sease", " ", art failure", m m myoca ca ard rd rdial infarction", " " "he he heart failure", " " "i isc c ch hemic hear art t di d d se seas as se" ", "s "s "sud ud udde den n n c ca card d dia a ac ar r rre e est", , a a and "a ac acu u ute e co coro rona nary ry y syn yndr dr dro om ome" e" e". Re Re Refe fer re renc nc ce e i ist st sts s s of of of r ret etri ri riev ev eved ed ar rt rtic icl le les s we w re re e m m man an anua u uall lly y y sc sc scan an anne ne ed d d f f for r r al l ll l re re rele le leva va ant nt n a add dd ddit it i i io on onal al s s stu tu t di di d es es s a a and nd re ev evie iew w w articles. We r res es e tr tr t ic ic cte te ed d th th he se se sear ar a ch ch h t t to o st st s ud ud udi ies es es o o on n n hu hu huma ma mans ns n t t tha ha hat t t we we were re re w wri ri ritt tt ten en en i i in n n En En Engl gl glis is ish. h. h. aortic stiffness, or venous thrombus; 4) no confounders were adjusted for.
Data extraction and quality assessment
One author (M. D.) assessed study eligibility and extracted the data, the other author (A. S.) independently double-checked the available data. The following data were extracted from each study: first author's name, year of publication, geographical location, follow-up time, sex, age, number of CVD events, number of participants/person-years of follow up, categories of coffee consumption, mean/median coffee consumption in each category, CVD assessment method, covariates adjusted for in the multivariable analysis, and relative risks and the associated measure of variance for all categories of coffee consumption. For cohorts with published data on several CVD outcomes, we chose incidence instead of mortality or heart failure results. For studies with data on both CHD and stroke as the outcome, we included both in the meta-analysis.
The correlation of CHD and stroke was accounted for in the main analysis (see below). In a sensitivity analysis, we analyzed one of the two outcomes. The Newcastle-Ottawa quality assessment scale (NOS) 22 was used to evaluate the quality of the included studies. M. D. and S.
B. developed the evaluation criteria (supplemental table 1 ). The score ranges from 0 to 9 points with a higher score indicating higher study quality.
To perform a dose-response meta-analysis, we assigned the median coffee consumption in each category of consumption to the corresponding relative risk for each study. We used means for this purpose if medians were not reported. If neither the mean nor the median consumption per category was reported, the midpoint of the upper and lower boundaries in each category was used to estimate median consumption. If the upper boundary for the highest category was not provided, the assigned median value was 25% higher than the lower boundary of that category. If the lower boundary for the lowest category was not provided, the assigned everal CVD outcomes, we chose incidence instead of mortality or heart failure r r res esul u u t ts s. Fo Fo For r r d tudies with data on both CHD and stroke as the outcome, we included both in the meta-analysis
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Data Synthesis and Analysis
To analyze the trend of coffee consumption and risk of CVD, we used both semi-parametric and parametric methods. For the semi-parametric method, four coffee consumption groups were generated, namely lowest, third highest, second highest, and highest. For each study that was included, the lowest and the highest coffee consumption categories corresponded to the lowest and highest groups, respectively. For studies with four exposure categories, the second and third categories corresponded to the second and third highest groups, respectively. For studies with three exposure categories, the middle category corresponded to either the second or the third highest group in the meta-analysis, depending on the similarity of the median coffee consumption to either the second or the third highest group of the meta-analysis. If the study had more than four exposure categories, two consumption groups, other than the lowest and highest,
were chosen based on their similarity of the amount of coffee consumption in that category to the second and third highest groups of the meta-analysis. For each group, we computed correlation coefficients ( ) between CHD and stroke outcomes in the same cohort. We imputed =1 initially to obtain the most conservative effect estimates. A random-effects model was used first and was changed to a fixed-effects model if no between study heterogeneity was found for the randomeffects model (tau-squared < 1). 23 Sensitivity analysis was conducted by imputing different (0 < 1) to evaluate the robustness of the effect estimates. We used the STATA command ROBUMETA to obtain the effect estimates.
For the parametric method, a dose-response meta-analysis was performed. 24 The number of cases and participants in each coffee consumption category was extracted to estimate the covariance of the relative risk in each study. Together with the observed adjusted variance of the highest group in the meta-analysis, depending on the similarity of the median co of ff ffee ee e consumption to either the second or the third highest group of the meta-analysis. If the study had mo more re re t t tha ha han n n fo fo fou u ur e exp xp xpo osure categories, two consum m mp pt p i io on groups, othe he h r th han an an m m m the lowest and highest, w wer re re chosen ba bas se ed d d on on the he heir ir ir s s sim im imil ilar ar arit it ty y of of f the e am m mou un unt t of f f c c cof off fe f e e e co co ons s sum ump p pti io on n in in in t tha ha at t t ca ca ate tego o ory ry t t to o the e eco co cond nd nd a and nd d t t thi h hird rd h hig ig i h he est st t g gro roup up ups s s of of of t t the he m m met et eta a-a-an an na a aly ly ysi i is. s F For or or e e eac ac ch h h gr gr grou ou oup, p, p w w we e e co co omp mp mput ut ted ed ed co o orre re ela lat ti tion on n coefficients ( ( ( ) ) ) be be betw tw twee ee en n n CH CH HD D D an an and d d st st stro roke ke k o o out ut u co co come me m s s s in in i t the he he s s sam am ame e e co c c ho ho hort rt rt. . We We We i imp mp mput ut uted ed ed =1 initiall ly y relative risk, we estimated the variance/covariance matrix of the data. The weight of each study was calculated as the inverse of the variance/covariance matrix. We used generalized least squares models (GLST) with the maximum likelihood method to estimate the coefficients for each study. We fit a fixed-effects generalized linear model first, and changed to a random-effects generalized linear model if the p value for the goodness of fit/heterogeneity of the previous model was < 0.05. Additionally, we tested for potential non-linearity in the association between coffee consumption and CVD risk using a fixed/random-effects restricted cubic spline model with 3 knots. In sensitivity analysis, we used two-stage fixed/random-effects dose response models to combine studies that reported results for categorized coffee consumption and studies with reported results for continuous coffee consumption. Specifically, the RR of CVD per unit increase of coffee consumption for each study was first estimated separately by GLST, and then the RRs from all of the studies were pooled together by a fixed/random-effects model. We used the STATA command GLST for model fitting, and the command LINCOME to obtain effect estimates for the fitted model.
We performed stratified analyses by baseline hypertension or MI of the study population, smoking status, publication year, NOS study quality score, dietary assessment method, evaluation of stroke or CHD as the outcome, country, sex, and type of coffee (caffeinated coffee or decaffeinated coffee). The interaction between categorized coffee consumption and the stratifying variable with the risk of CVD was tested by a likelihood ratio test comparing the models derived using GLST method with and without the interaction terms. We assessed the potential for publication bias using Egger's regression symmetry test. 25 All analyses were conducted using STATA Version 11.2 (STATA Corp, College Station, Texas).
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Results

Characteristics of studies
Our initial search identified 2587 potentially relevant citations. After screening titles and abstracts, we identified 53 studies for further evaluation. Of the 53 initially included studies, we excluded 14 studies due to duplicate publication, one study with point estimate without standard error, and one nested case control study with a retrospective design. Thirty-six studies remained in the meta-analysis (Figure 1) . other CVD cases. Characteristics of these 36 studies are shown in Table 1 . One study had a nested case-control study design, one had a case-cohort study design, and the rest of the studies were cohort studies. Duration of follow-up for incident CVD ranged from 6 to 44 years, with a median follow-up of 10 years. Twenty-one studies were conducted in Europe, 12 in the US, and 3 in Japan. Three studies assessed coffee consumption repeatedly during the course of the follow-up, and the rest of the studies assessed coffee consumption at baseline. Thirteen studies assessed coffee consumption without using a specific dietary assessment method, and the rest of the studies assessed coffee consumption by diet recalls, diet records or food frequency questionnaires (FFQ). One study modeled coffee consumption as a continuous variable, and the remaining studies modeled coffee consumption categorically. Nine studies assessed the association of caffeinated coffee consumption with CVD risk, and four studies assessed the association of decaffeinated coffee consumption with CVD risk. The outcome in 17 studies was risk of stroke, while the outcome in 22 studies was risk of CHD. The scores of the NOS quality assessment ranged from 3 to 8, and 31 studies had scores of 5 or higher. The corresponding results of each criteria of the NOS quality assessment for our meta-analysis are shown in nested case-control study design, one had a case-cohort study design, and the rest st t o of f f th h he e st st stud ud udie ies s were cohort studies. Duration of follow-up for incident CVD ranged from 6 to 44 years, with a me medi di dian an an f f fol ol ollo lo low w w-up up p o of 10 years. Twenty-one studi di ies e e w were conducte e ed d d in n E E Eu ur urope, 12 in the US, and 3 in n n J Japan. Th hre ree e e s s stud ud die i s s s as ass se ses ss ssed ed d c c cof of o f f fee e e cons ns sump pt pti ion n re re repe pe eat t ted edl ly y d dur ur n in ing g th the e e c co cour urse se s o of f f th h he e fo oll ll llow ow ow-u -u up, p, p, a a and n nd t the he he r res es st t o of of t the e e st t tud ud udie ie ies s a as sse se ess ss sse ed ed c c cof of ffe ee e c c cons ns nsum um umpt pt ptio io on n t t t at at at b b bas asel elin in ne. e. e T T Thi hi hirt rt rtee en n n s st stud ud die ies s s assessed cof ffe fe ee e e co co ons ns nsum um umpt p p io io on n n wi wi ith th thou ou ut t us us usin in ng g g a a a sp sp spec ec ecif if ific ic ic d die ie ieta ta ary ry ry a a ass ss sse ess ss sme me ment nt nt m m met et e ho ho hod, d, d, a a and nd nd the rest of f f Supplemental Table 1 . The study modeling coffee as a continuous exposure was excluded in the following analysis due to the difficulty of combining the risk estimate with those of other studies and was only included in the sensitivity analysis. 26 All of the remaining 35 studies were included in the main analysis, and 29 studies were included in the dose-response analysis between coffee consumption and risk of CVD.
Coffee consumption and risk of CVD
The relative risks for CVD with different coffee consumption categories relative to the lowest category are shown in ). L L Low ow ow b bet e etw we wee e ent tud ud udy y y va va v ri rian an anc ce ces s of of of C CVD VD VD r ris isk k we we were re re f f fou ound nd nd f f for or or e eac ac ach h ca a ate tego go gory ry ry o of f f co co c ff ff f ee ee ee c co on onsu su s mp mp mpti ti tion on n ( ( (t ta tau-u--sua uar r red d d = 0.00 for the r ran an ando do dom-m-m ef ef ffe fe fect ts s s mo mo m de de dels ls), ), ), a and nd n t t the he he i i imp mp mput ut uted ed ed co co orr rr rrel el elat at a io io ion n n co o oef ef ffi fi fici ci cien en ent t be be betw tw twee ee een n n the risks of f CVD risk were observed (all P for interactions >0.05) (Figure 3) . Only 4 studies provided the stratified results by age. [27] [28] [29] [30] The summarized results showed that, comparing the highest with the lowest intakes, the RR of CVD was 0.96 (95% CI, 0.65 to 1.42) for age < 65 years, and the RR was 0.91 (95% CI, 0.59 to 1.40) for age 65 years. 
Dose-response analysis of coffee consumption with risk of CVD
In our dose-response analysis, we observed a non-linear association between coffee consumption and risk of CVD (P for non-linearity < 0.001) with a significant trend (P for trend <0.001) and limited heterogeneity in study results (P for heterogeneity = 0.09) ( n n o o our ur ur d d dos ose-e-e-r re resp sp pon on onse se a a ana na aly lysi is, s, s w w we e e ob ob obse se erv rv ved ed ed a n n no o on n-n-li li ine ne ear ar r a a as ss ssoc oc cia ia i t t tion on on b be e etw we ween en n c c cof of o fe fe fee e e co o ons s sum um mpt ptio ion and risk of CV CV VD D D (P (P (P f for or or n n non n n-l -l lin in i ea ea ear r rit ity y y < 0. 0. 0 00 00 001) 1) 1) w w wit it th h h a a a si s gn gn gnif if ific ic ican an nt t t tr tr t en en end d d (P (P P f f for or or t tre re rend nd nd < < <0. 0. 0 001) and stroke (Figures 4b and 4c ). There was stronger evidence for heterogeneity in study results for the association of coffee consumption with CHD risk (P heterogeneity=0.001) than for the association with stroke risk (P heterogeneity=0.07).
We further explored the reason for the heterogeneity between coffee consumption and CHD risk by stratifying the studies by publication year ( 2000 or > 2000). We found that in studies published in year 2000 or earlier, coffee consumption was not significantly associated with CHD risk (n=13, P for heterogeneity = 0.20), whereas in later studies, coffee consumption was non-linearly associated with CHD risk (n= 18, P for heterogeneity = 0.08). We didn't perform a similar analysis for stroke because very few studies on stroke were published prior to
2000.
Sensitivity analysis
We tested the robustness of our results in sensitivity analyses. Because the RRs of stroke and CHD from the same cohort were correlated and a total of 6 studies included both CHD and stroke results, we conducted a sensitivity analysis by including only one outcome at a time. Our results remained largely unchanged and non-linear curves were found with including either CHD or stroke as the outcome (Supplemental Figure 1a and 1b).
One study with coffee consumption modeled as a continuous variable was excluded from the main analysis; 26 we added the RR from this study to the dose-response analysis by a two stage method and the results did not substantially change.
To test whether the association between coffee consumption and risk of CVD was different for unadjusted and multivariable adjusted models, we performed a dose-response metaanalysis of the only age-adjusted data including 34 comparisons (Supplemental Figure 2) .
Multivariate adjustment strengthened the inverse association between moderate consumption and 2000.
We We e t t tes es este te ted d 
Publication bias
The Egger test did not suggest publication bias for associations for any category of coffee consumption and risk of CVD (Supplemental Figure 3 and Table 2 ).
Discussion
The findings from this systematic review and meta-analysis, based on approximately 1,283,685 study participants and 47,779 CVD cases, including about 28,347 CHD cases, 12,030 stroke cases and 7,402 other CVD cases, demonstrate a non-linear association between coffee consumption and risk of CVD. Moderate coffee consumption (3-5 cups/day) was associated with lower CVD risk, and heavy coffee consumption ( 6 cups/day) was neither associated with a higher nor a lower risk of CVD.
In contrast to our results, a previous meta-analysis summarizing 21 prospective cohort studies 31 found no association between moderate coffee consumption and CHD risk in the overall population. One possible reason is that the previous meta-analysis included 7 studies without adjustment for confounders, which might have biased the relative risks upwards because of confounding by factors such as smoking.
A recent cohort study by Liu et al 32 found that 4 cups per day of coffee consumption was associated with increased mortality, but the association was only significant for participants under 55 years old. The results from this study contradict those from this meta-analysis and the majority of studies in the literature. Possible reasons for this discrepancy include a relatively small size, lack of updated dietary assessment, and subgroup analysis. In our meta-analysis, stratified analysis by age revealed no significant differences in the association across age groups.
consumption and risk of CVD. Moderate coffee consumption (3-5 cups/day) wa as s s as s sso soci ci ciat at ated ed ed w with ower CVD risk, and heavy coffee consumption ( 6 cups/day) was neither associated with a hi igh gh gher er r n n nor or r a a a l l low ower er er r risk of CVD.
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The debate about the relation between coffee consumption and CVD risk mainly stemmed from inconsistent results according to different study designs. Case-control studies, which are prone to recall bias and selection bias, tended to show a positive association, whereas cohort studies generally showed a null association. 10 Still, findings from prospective cohort studies on coffee consumption and CVD risk have remained inconsistent. Differences among studies in sample sizes, the characteristics of the study populations, the assessment methods for coffee consumption, and statistical adjustments may have contributed to divergent results. Since the true association between coffee consumption and CVD risk is likely to be modest and nonlinear, the differences in coffee assessments and covariate adjustments may result in changes the magnitude and even the direction of the associations and thus lead to different conclusions.
The U-shaped association between coffee consumption and CVD risk observed in this meta-analysis need to be considered from both methodological and biological points of view.
First, individuals with hypertension or other conditions related to CVD risk might have changed their coffee consumption before baseline. Thus, baseline disease, especially hypertension, as a confounder could result in reverse causation. However, we observed no significant difference in the association between coffee consumption and CVD risk between cohorts with hypertensive and MI patients and the general population cohorts. Second, smoking is likely to be an important confounder for the association between coffee consumption and CVD risk, and could bias the relative risks upwards. Heavy coffee consumption was associated with higher risk of CVD in age-adjusted analyses, but this is likely due to confounding by smoking. After adjustment for smoking and other covariates, heavy coffee was consumption was not significantly associated with CVD and the inverse association between moderate consumption and CVD became stronger.
The non-linear U-shaped between coffee consumption and CVD risk might also be true he magnitude and even the direction of the associations and thus lead to differen nt nt c c con oncl cl clus us usio io ions ns n .
The U-shaped association between coffee consumption and CVD risk observed in this me meta ta ta-a -a an na naly ly lysi si sis s s ne e eed ed ed t to be considered from both m me met th hodological and nd n bio io olo lo log gical points of view.
F Firs s st t, individua uals ls ls w w wit th h h hy hy ype pe pert rt rten en ensi sion on on o or r o ot ther r r c co ond dit ti ions ns s r r rel ela a ate ed ed t to o C CVD VD D r ris isk k k mi mi m gh gh ht t t ha ha have ve e c c cha h hang ng nge ed h hei ei eir r co co coff ffee ee e c c con ons sum mp mpt ti ion on n b bef f for or o e e e ba ba bas se seli li ine ne ne. . Th Th Thus us us, , b b bas se seli i ine ne e d d di is isea ea ease se e, , es es espe pe p c c cia al ally ly y h hyp yp yper er rte te ens si i ion n, n, a as s s a a a confounder c cou ou ould ld l r r res es e ul ul u t t t in n r r rev ev ever er rs s se e e ca ca caus s sat at atio io ion. n. n H H How ow wev ev ever e , , we we we o o obs bs bser er erve ve ed d d no no no s s sig ig igni ni n fi fi fica ca cant nt nt d d dif i ference in n based on plausible biological mechanisms. Coffee is a complex chemical mixture with hundreds of compounds including the phenolic compound chlorogenic acid, caffeine, minerals such as potassium and magnesium, niacin and its precursor trigonelline, and lignans. Coffee consumption has been associated with higher insulin sensitivity, a lower risk of type 2 diabetes, and lower concentrations of inflammatory markers such as C-reactive protein and E-selectin. 33, 34 However, short-term metabolic studies have shown that caffeine can acutely increase blood pressure by antagonizing the adenosine A1 and A2A receptor, [35] [36] [37] and could also acutely adversely affect arterial stiffness and endothelium dependent vasodilation. 38, 39 Long-term heavy coffee consumption has been associated with a slightly elevated risk of hypertension, 40 and a higher level of plasma homocysteine. 41, 42 In addition, cafestol in unfiltered coffee increases serum total cholesterol concentrations. 43 The non-linear U-shaped between coffee consumption and risk of CVD might be due to a combination of beneficial and detrimental effects: for moderate coffee consumption, beneficial effects may be greater than adverse effects; whereas for heavy consumption, detrimental effect may counterbalance beneficial effects. Results from case crossover studies suggest that coffee consumption transiently increases risk of nonfatal myocardial infarction, ischemic stroke onset, and sudden cardiac death. [44] [45] [46] However, we could not differentiate acute effects from long-term effects of habitual coffee consumption in this study.
No significant association between decaffeinated coffee consumption with CVD risk was observed in this meta-analysis. There were several potential explanations. First, the consumption of decaffeinated coffee was much lower than caffeinated coffee, diminishing the power to detect any association. Second, the null association might be due to a reverse causation problem in that individuals with hypertension or other CVD-related conditions might switch from regular coffee to decaffeinated coffee. This reverse causation may mitigate an inverse association between higher level of plasma homocysteine. 41, 42 In addition, cafestol in unfiltered cof ffe fe ee in in i cr cr rea a ease se ses s s erum total cholesterol concentrations. 43 The be e e gr grea ea eate ter r th than an a adv dv dver ers se se e eff ffec ec ects ts s; ; wh wh whe er erea ea as s for he heav av avy y y co co c ns ns sum um umpt ptio ion n, n, d d det etri ri r me men nt n al al al e e eff ff ffec ect t t ma ma may y y co o oun un u t t ter rb rba al alan an nce ce ce b ben en ene e efic ic cia ia ial l ef ef effe fe f ct ct ts. s. s R R Res es sul ul ults f fro o om m c ca case se crossover stud ud die ie ies s su su sugg gg gges es est th th that at at c cof of offe fe f e e e co o ons ns nsum um ump p pti ti ion on n t tra ra rans ns sie ie ient nt ntly ly ly i i inc nc ncre rea a ase se es s s ri ri risk sk sk o of f f no no nonf nf nfat at atal a decaffeinated coffee consumption and CVD risk.
We did not observe a significant association between coffee consumption and CHD risk for earlier publications (2000 or earlier). There are two potential reasons for this finding. First, coffee brewing methods have changed over time and nowadays the filter method has become more popular, effectively replacing unfiltered forms of coffee such as boiled coffee that was more widely consumed by participants in earlier studies. It has been shown that drinking boiled coffee increases serum cholesterol, an important risk factor for CVD 5 . Second, in earlier studies, the sample size was typically small; the measurement of baseline characteristics was typically crude; statistical control of confounders such as diet was inadequate; and the average NOS study quality score was lower. Our stratified analysis showed that coffee consumption was not associated with CVD risk in subgroups with a lower NOS score.
A study by Cornelis MC et al. 47 showed that CYP1A2 genotype was an effect modifier between coffee consumption and risk of myocardial infarction: coffee consumption was related to higher risk of myocardial infarction for the slow caffeine metabolizer, and was not related to myocardial infarction for the fast caffeine metabolizer. However, this analysis was based on a case-control study conducted in Costa Rico and the results have not been replicated in prospective cohort studies yet.
Recently, a genome-wide association study (GWAS) found a highly significant association between a variant on CYP1A2 and coffee intake 48 . However, this variant explains only a very small population variance. Since the vast majority of our participants were Caucasians, the allele frequency was expected to be consistent across various cohorts. Ideally, the meta-analyses should be done according to different genotypes of CYP1A2. However, none of the included cohorts assessed the genotypes and thus we were unable to conduct such a quality score was lower. Our stratified analysis showed that coffee consumption n wa wa was s no no not t t associated with CVD risk in subgroups with a lower NOS score.
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Our meta-analysis has several strengthens. First, our meta-analysis included 35 cohort studies and 1,283,685 participants, which provided sufficient power to detect modest associations. Second, because of the prospective design of all included studies, differential misclassification of coffee consumption due to recall bias was minimized and the likelihood of selection bias is reduced. Third, we used both semi-parametric and parametric methods, and both analyses indicated a U-shaped relationship between coffee consumption and CVD risk. Finally, we conducted stratified analyses according to disease endpoints, geographic locations of the studies, type of coffee, and baseline characteristics of the study populations. The subgroup results are highly consistent and robust.
Our study also has several limitations. Given the observational nature of the studies, the possibility of residual confounding cannot be excluded. However, since higher coffee consumption was generally associated with a less healthy lifestyle such as a higher prevalence of cigarette smoking, less physical activity, and a less healthy diet, the observed association between moderate coffee consumption and a lower CVD risk is unlikely to be explained by these confounders. In addition, residual confounding by smoking may have biased the association for heavy coffee consumption upward, which may explain our finding that adjustment for smoking and other covariates actually strengthened the inverse association. Nonetheless, because of the observational nature of the included studies, a causal relationship cannot be established with these data alone. In addition, coffee brewing methods were not assessed in the included studies.
However, given coffee consumption habits in the studied populations most consumed coffee is likely to have been filtered coffee. As a result, our results may not apply to unfiltered coffee (e.g.
French press, Scandinavian boiled, or Turkish/Greek coffee).
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In conclusion, our meta-analysis suggests a non-linear relationship between coffee consumption and CVD risk. Moderate coffee consumption was associated with lower CVD risk, with the lowest CVD risk at 3 to 5 cups/d of coffee consumption, and heavy coffee consumption was not associated with CVD risk. This non-linear association with coffee consumption was observed for both the risk of CHD and stroke.
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